Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Sales Revenue, Goods, Net $ 53,459 $ 56,530
Sales Revenue, Services, Net 5,118 6,435
Total revenue 58,577 62,965
Cost of Goods Sold 31,829 36,119
Cost of Services 1,581 3,097
Total cost of revenue 33,410 39,216
Gross profit 25,167 23,749
Operating expenses:    
Research and development 7,375 12,367
Sales and marketing 8,290 10,344
General and administrative 6,602 7,991
Intangible amortization 4,189 4,764
Restructuring 165 3,155
Long-lived assets impairment 0 1,181
Total operating expenses 26,621 39,802
Operating income (loss) (1,454) (16,053)
Other income (expense), net 888 170
Income (loss) before income taxes (566) (15,883)
Income tax (expense) benefit 597 (58)
Net income (loss) $ 31 $ (15,941)
Net income (loss) per share:    
Basic $ 0.00 $ (1.04) [1]
Diluted $ 0.00 $ (1.04) [1]
Weighted-average number of shares outstanding:    
Basic 15,497 15,344 [1]
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options(2) [2] 210 0
Diluted 15,707 15,344 [1]
[1] All common stock (except authorized shares), equity share, and per share amounts have been retroactively adjusted to reflect a one-for-four reverse stock split, which was effective June 7, 2017.
[2] The Company has 0.3 million and 1.2 million shares represented by common stock equivalents for the twelve months ended March 31, 2018 and 2017, respectively, which were not included in the computation of average dilutive shares outstanding because they were anti-dilutive. In periods with a net loss from continuing operations, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation because they are anti-dilutive.